Business Wire

AGCO Chairman, President and Chief Executive Officer Martin Richenhagen Receives the French Government's Prestigious Legion of Honor

Jaa

AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and solutions, today announces that Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO Corporation, has been named a Chevalier (Knight) of the Légion d'Honneur (Legion of Honor) by the government of France. This high-ranking honorary decoration was bestowed during a recent ceremony held at AGCO’s global headquarters in Duluth, in the presence of the French Consul General in Atlanta, Louis de Corail.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181016005270/en/

Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO Corporation, has been na ...

Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO Corporation, has been named a Chevalier (Knight) of the Légion d'Honneur (Legion of Honor) by the government of France during a recent ceremony in Duluth, Georgia, USA. (Photo: Business Wire)

The Legion of Honor, established by Napoléon Bonaparte in 1802, is the highest distinction conferred by the government of France. It is awarded to recognize those people and organizations that have made outstanding contributions to France in a variety of fields.

AGCO began operations in France, when the group became the parent company of the Massey Ferguson brand in 1994, taking ownership of the Beauvais Massey Ferguson plant. Opened in 1960, the Beauvais AGCO site remains today the Global Centre of Excellence for Massey Ferguson engineering and manufacturing, as well as the first private employer of the whole Picardie region. Summing up its operations from Beauvais, Ennery and Courcouronnes, as well as its joint ventures GIMA and AGCO Finance, AGCO has approximately 2,500 employees in the country. As continental Europe's second largest economy, and one of the largest markets for farm machinery, France represents a strategically important market for AGCO. In France, AGCO actively drives business activities centered on the design, manufacture and distribution of farm machinery, strongly contributing to the French economy.

This decoration is in recognition, under Martin Richenhagen’s leadership, of AGCO’s contributions to the development of France and France-USA relations.

Conferring the Legion of Honor on behalf of French President Emmanuel Macron, Dr. Monique Seefried, Chevalier in the Order of the Legion of Honor said: "I would like to thank Martin Richenhagen for his personal commitment and trust in our country's economy. I pay tribute, through him, to the strength of AGCO Corporation, a global leader in the design, manufacture and distribution of agricultural machinery and solutions, and to its willingness to expand and develop in Europe, and especially in France where AGCO’s French-made tractors are admired and respected. Tractors embody our past and our future, linking our ancient human roots in agriculture to the technological progress of the 20th century. Tractors bring us back to the land, to the oldest profession of farming while heralding the power of machinery and industry.”

Martin Richenhagen commented: “It is indeed an honor and privilege to receive this prestigious decoration from the French Government. I am delighted and proud to have our French operations receive such high recognition. In developing our business in Europe, a region which for AGCO is first in revenue contribution, France is a strategic market of great importance. During the past six years, we have invested more than 300 million euros in our Beauvais and Ennery operations, creating close to 300 new jobs to support our ambition for growth. This would not have been possible without the outstanding commitment of our 2,500 employees and this recognition is also theirs. We truly consider France as a business friendly environment supported by an entrepreneurial policy led by President Emmanuel Macron. We hope to make ever-more progress in our development, to contribute to further growing the relationship between France and the USA.”

Martin Richenhagen was selected by the Board of Directors in March 2004 as President and Chief Executive Officer of AGCO Corporation. He was appointed to Chairman of the Board on August 15, 2006.

Under his leadership, AGCO’s operations in France has been through outstanding transformation and success including the following key milestones:

  • 2013 – The Beauvais 2 Cab facility and International Sales Training Centre for the Massey Ferguson brand opens. This 15.5 million euros investment created 100 new jobs.
  • 2016 – The Beauvais site receives two coveted awards: Best Foreign Exporter 2016 as the first producer and exporter of farm machinery in France; and Factory of Year 2016 for its lean manufacturing implementation and number one in quality approach.
  • 2017 – At Ennery, AGCO’s European Parts Warehouse and Distribution Centre moves from 30,000 m² to 100,000 m² and will create 62 jobs by the end of 2018 after a 2.1 million euros investment.
  • 2018 – Only five years after the opening of its new cab facility, on August 28th, AGCO launches the operations of its new Logistic Centre in Beauvais after investing another 11 million euros and creating 103 new jobs.

About AGCO

AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural solutions and supports more productive farming through its full line of equipment and related services. AGCO products are sold through five core brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by Fuse® precision technologies and farm optimization services. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2017, AGCO had net sales of approximately $8.3 billion. For more information, visit http://www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.

Contact information

AGCO
Ulrich Stockheim, +1 770-813-6002
Chief Communications Officer
Ulrich.Stockheim@AGCOcorp.com
Cell: +49 1732993545
or
Xavier Arruego, +33 3 44 11 29 40
Manager, Public Relations AGCO EME
Xavier.Arruego@AGCOcorp.com
Cell: +33 6 70 65 77 00

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease21.1.2019 12:00Tiedote

Vertex Pharmaceuticals (Europe) Limited today announced that the European Commission has granted approval of the label extension for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of children with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. “Today’s approval by the European Commission brings us one step closer to our goal of bringing treatment to all people living with CF,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. ‘‘By treating the underlying cause of disease early, we can potentially modify its course and offer patients the chance of improved outcomes.’’ The label update is based on data from a Phase 3 open-label safety study in 60 patients that showed treatment with lumacaftor/ivacaftor was generally well tolerated for 24 weeks, with a safety profile in these pediatric patients generally consistent with

Anticipation Builds as MWC19 Barcelona Approaches21.1.2019 12:00Tiedote

The GSMA today announced final updates for MWC19 Barcelona (formerly Mobile World Congress), including additional keynote speakers, participating companies, programmes and events. Taking place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet, MWC19 Barcelona is set to attract more than 107,000 professionals from over 200 countries and territories. “With the anticipated arrival of 5G, this year’s event is set to be one of the most exciting as the industry convenes to showcase Intelligent Connectivity across new technologies on the brink of reaching millions of people across the world,” said John Hoffman, CEO, GSMA Ltd. “Over the four days of MWC19, attendees will have the opportunity to hear from leaders who are driving innovation and we look forward once again to welcoming the mobile world to Barcelona.” Global Leaders to Keynote The GSMA announced the addition of several new keynote speakers for MWC19 including executives from lea

B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution21.1.2019 12:00Tiedote

B2C2, one of the largest cryptocurrency liquidity providers and the leader in electronic OTC trading, today announced the launch of streaming pricing with point-and-click execution on its OTC platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005063/en/ Max Boonen, Founder and CEO of B2C2 (Photo: Business Wire) For the first time, B2C2’s clients will be able to view and execute trades on a real-time two-way market, via the firm’s secure web interface. The new functionality allows market participants to easily monitor live pricing in user-defined quantities and execute with the click of a button, as they would on traditional FX trading platforms. The launch rounds out a number of milestones for B2C2 in 2018, including surpassing 2017 peak volumes; rolling out a completely redesigned front-end; forming integration partnerships with the major liquidity hubs; and launching a research offering. Founded in 2015, B2C2 i

Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel21.1.2019 11:00Tiedote

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma, Israel’s leading commercial partner for innovative pharmaceuticals, announced today an exclusive agreement to commercialize ONPATTRO®, the first-ever commercialized RNAi therapeutic, as well as other investigational therapeutics under development in the Alnylam RNAi portfolio. “Our partnership with Medison marks an important step in our global commercial expansion and signals our intent to ensure that patients suffering from serious rare diseases have access to our medicines, regardless of location,” said Theresa Heggie, SVP and Head of Europe, Middle East and Africa, and Canada, Alnylam Pharmaceuticals. “Medison has a strong organization with a proven track record of commercializing orphan products successfully, together with an infrastructure uniquely suited to supporting patients suffering from rare diseases in Israel and providing access to our potentially transformational thera

Gore Introduces GORE® TAG® Conformable Thoracic Stent Graft with Reduced Profiles in Europe21.1.2019 11:00Tiedote

W. L. Gore & Associates, Inc. (Gore) today introduced reduced profiles for the most commonly used diameters of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile allows physicians to perform TEVAR in patients with smaller vessels where access is challenging and aortic anatomy is tortuous, expanding the availability of Gore’s thoracic stent graft to a greater population of patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190121005042/en/ GORE(R) TAG(R) Conformable Thoracic Stent Graft with ACTIVE CONTROL System (Photo: Business Wire) The GORE® TAG® Conformable Thoracic Stent Graft was modified to reduce the delivery profile of the 31, 37, and 40 mm device diameters by 2 Fr for all lengths. The reduction in profile, through the use of a smaller diameter primary sleeve, is the only change to the device. The stent graft leverages the same predictable outcomes of the time-teste

HCL 2030 Ecosystem Platform to Explore Societal Implications of Emerging Technology at the World Economic Forum21.1.2019 10:26Tiedote

HCL Technologies (HCL), a leading global technology company and the World Economic Forum’s Strategic Partner, today announced its largest presence to date at the side-lines of World Economic Forum’s Annual Meeting in Davos scheduled from 21st January 2019 to 25th January 2019. The company will host a three-day event in a special Pavilion that will feature a technology showcase, thought-leadership programs, as well as a number of high-level networking and social events throughout the tenure of the conference. The overarching theme of the HCL and Fast Company programs will explore how humanity’s relationship with technology will evolve through the next decade of rapid innovation. HCL has partnered with Fast Company to develop a thought-leadership track that includes three panel discussion breakfasts. As part of the theme of Human-Machine Harmony, HCL is launching the HCL 2030 Platform, together with its ecosystem of partners and stakeholders, that will conduct in-depth explorations and d

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme